次世代シーケンシング(NGS)の世界市場2019-2023

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TECHNOLOGY
• Market segmentation by technology
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Consumables – Market size and forecast 2018-2023
• Equipment – Market size and forecast 2018-2023
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
PART 10: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Advances in NGS techniques
• Reduced costs of gene sequencing
• Developments in the field of bioinformatics and cloud-based software
• programs
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bio-Rad Laboratories Inc.
• Eurofins GSC Lux Sarl
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Invitae Corp.
• Laboratory Corp. of America Holdings
• Merck KGaA
• PerkinElmer Inc.
• QIAGEN Group
• Thermo Fisher Scientific Inc.
PART 16: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 17: EXPLORE TECHNAVIO

Exhibit 01: Vendor offering overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Consumables – Year-over-year growth 2019-2023 (%)
Exhibit 22: Equipment – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Equipment – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by end-user 2018 (%)
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 46: Bio-Rad Laboratories Inc. – Business segments
Exhibit 47: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 48: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 49: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 50: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 51: Eurofins GSC Lux Sarl – Vendor overview
Exhibit 52: Eurofins GSC Lux Sarl – Business segments
Exhibit 53: Eurofins GSC Lux Sarl – Organizational developments
Exhibit 54: Eurofins GSC Lux Sarl – Geographic focus
Exhibit 55: Eurofins GSC Lux Sarl – Segment focus
Exhibit 56: Eurofins GSC Lux Sarl – Key offerings
Exhibit 57: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 58: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 59: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 60: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 61: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 62: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 63: Illumina Inc. – Vendor overview
Exhibit 64: Illumina Inc. – Business segments
Exhibit 65: Illumina Inc. – Organizational developments
Exhibit 66: Illumina Inc. – Geographic focus
Exhibit 67: Illumina Inc. – Segment focus
Exhibit 68: Illumina Inc. – Key offerings
Exhibit 69: Invitae Corp. – Vendor overview
Exhibit 70: Invitae Corp. – Business segments
Exhibit 71: Invitae Corp. – Organizational developments
Exhibit 72: Invitae Corp. – Geographic focus
Exhibit 73: Invitae Corp. – Key offerings
Exhibit 74: Laboratory Corp. of America Holdings – Vendor overview
Exhibit 75: Laboratory Corp. of America Holdings – Business segments
Exhibit 76: Laboratory Corp. of America Holdings – Organizational developments
Exhibit 77: Laboratory Corp. of America Holdings – Geographic focus
Exhibit 78: Laboratory Corp. of America Holdings – Segment focus
Exhibit 79: Laboratory Corp. of America Holdings – Key offerings
Exhibit 80: Merck KGaA – Vendor overview
Exhibit 81: Merck KGaA – Business segments
Exhibit 82: Merck KGaA – Organizational developments
Exhibit 83: Merck KGaA – Geographic focus
Exhibit 84: Merck KGaA – Segment focus
Exhibit 85: Merck KGaA – Key offerings
Exhibit 86: PerkinElmer Inc. – Vendor overview
Exhibit 87: PerkinElmer Inc. – Business segments
Exhibit 88: PerkinElmer Inc. – Organizational developments
Exhibit 89: PerkinElmer Inc. – Geographic focus
Exhibit 90: PerkinElmer Inc. – Segment focus
Exhibit 91: PerkinElmer Inc. – Key offerings
Exhibit 92: QIAGEN Group – Vendor overview
Exhibit 93: QIAGEN Group – Product segments
Exhibit 94: QIAGEN Group – Organizational developments
Exhibit 95: QIAGEN Group – Geographic focus
Exhibit 96: QIAGEN Group – Segment focus
Exhibit 97: QIAGEN Group – Key offerings
Exhibit 98: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 99: Thermo Fisher Scientific Inc. – Business segments
Exhibit 100: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 101: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 102: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 103: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 104: Validation techniques employed for market sizing
Exhibit 105: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様